132
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Preparation and In Vitro Evaluation of Controlled Release Hydrophilic Matrix Tablets of Ketorolac Tromethamine Using Factorial Design

&
Pages 903-910 | Published online: 25 Sep 2008

REFERENCES

  • Ağabeyoğlu T. İ. Dissol; A basic computer program for the kinetic assesment of dissolution data. Presented at National Pharmaceutical Congress, İstanbul 1984
  • Baveja S. K., Ranga-Rao K. V., Padmalatha Devi K. Zero-order release hydrophilic matrix tablets of β-adrenergic blockers. Int. J. Pharm. 1987; 39: 39–45
  • Bettini R., Colombo P., Massimo G., Catellani P. L., Vitali T. Swelling and drug release in hydrogel matrices; polymer viscosity and matrix porosity effects. Eur. J. Pharm. Sci. 1994; 2: 213–219
  • Beuving G. Validation of Analytical Methods. Validation Seminar, Istanbul, 31 May–01 June, 2001
  • Bravo S. A., Lamas M. C., Salomon C. J. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices. J. Pharm. Pharm. Sci. 2002; 5(3)213–219
  • Buckley M. M.-T., Brogden R. N. Ketorolac, A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990; 39(1)86–109
  • Caporal-Gautier J., Nivet J. M., Algranti P., Guilloteau M., Histe M., Lallier M., N'guyen-Huu J. J., Russotto R. Guide de validation analytique rapport d'une commission SFSTP I. Methodology. STP. Pharma Prat. 1992; 2(4)205–226
  • Çelebi N., Ünlü G. Formulation and evaluation of hydrophilic matrix tablets of diltiazem using factorial design based studies. Pharmazie 1999; 54(12)910–914
  • Colombo P., Bettini R., Peppas N. A. Observation of swelling process and diffusion front position during swelling in HPMC matrices containing a soluble drug. J. Control. Release 1999; 61(1–2)83–91
  • Ford J. L., Rubinstein M. H., Mclaul F., Hogan J. E., Edgarp J. Importance of drug type, tablet shape and added diluents on drug release kinetics from HPMC matrix tablets. Int. J. Pharm. 1987; 40: 223–234
  • Handbook of pharmaceutical excipients3rd, A. H. Kibbe. Pharmaceutical Press (PhP), Washington, DC 2000; 84–256, American Pharmaceutical Association (APhA)
  • Hashim A., Wan Po L. A. Improving the release characteristics of water-soluble drugs from hydrophilic sustained release matrices by in situ gas generation. Int. J. Pharm. 1987; 35: 201–209
  • Heng P. W. S., Chan L. W., Easterbrook M. G., Li X. Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets. J. Control. Release 2001; 76(1–2)39–49
  • Higuchi T. Mechanism of sustained-action medication, theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963; 52(12)1145–1149
  • Juárez H., Rico G., Villafuerte L. Influence of admixed CMC on release of 4-amino-pyridine from HPMC matrix tablets. Int. J. Pharm. 2001; 216(1–2)115–125
  • Kamath B. V., Shivram K., Vangani S. Spectrophotometric determination of Ketorolac tromethamine by charge transfer and ion-pair complexation. Anal. Lett. 1994; 27(1)103–112
  • Design and analysis of experiments, D. C. Montgomery. Copyright, by John & Sons, Inc, New York 1997; 290, Chapter 7,
  • Mroszczak E. J., Lee F. W., Combs D., Sarnquist F. H., Huang B.-L., Wu A. T., Tokes L. G., Maddox M. L., Cho D. K. Ketorolac tromethamine absorption, distribution, metabolism, excretion and pharmacokinetics in animals and humans. Drug Metab. Dispos. 1987; 15(5)618–626
  • Development and validation of analytical methods. Progress in pharmaceutical and biomedical analysis1st, C. M. Riley, T. W. Rosanske. Elsevier Science Inc, New York, NY 1996; 3: 20–22
  • Reynolds T. D., Mitchell S. A., Balwinski K. M. Investigation of the effect of tablet surface area/volume on drug release from HPMC controlled-release matrix tablets. Drug Dev. Ind. Pharm. 2002; 28(4)457–466
  • Tiwari S. B., Murthy T. K., Pai M. R., Mehta P. R., Chowdary P. B. Controlled release formulations of Tramadol HCl using hydrophilic and hydrophobic matrix system. AAPS Pharm. Sci. Tech. 2003; 4(3)1–6
  • The United States Pharmacopeia (USP 24), The National Formulary (NF 19) (2000). Rockville, MD: United States Pharmacopeial Convention, Inc.
  • Vázquez M.-V., Casalderry M., Duro R., Gómez-Amoza J.-L., Martínez-Pacheco R., Souto C., Concheiro A. Atenolol release from hydrophilic matrix tablets with HPMC mixtures as gelling agent: Effects of the HPMC mixture. Eur. J. Pharm. Sci. 1996; 4: 9–48
  • Vazquez M. J., Perez-Marcos B., Gomez-Amoza J. L., Martinez-Pacheco R., Souto C., Concheiro A. Influence of technological variables on release of drugs from hydrophilic matrices. Drug Dev. Ind. Pharm. 1992; 18(11–12)1355–1375

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.